Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer

Clinical Outcomes ◽

Specific Antigen ◽

Androgen Deprivation ◽

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12313 ◽

2014 ◽

Vol 13 (2) ◽

pp. e65-e71 ◽

Cited By ~ 2

Author(s):

Jeremy Yuen Chun Teoh ◽

James Hok Leung Tsu ◽

Steffi Kar Kei Yuen ◽

Samson Yun Sang Chan ◽

Peter Ka Fung Chiu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Specific Antigen ◽

Androgen Deprivation ◽

Survival Outcomes ◽

MP-16.03 Nadir Prostate Specific Antigen (PSA) Level and Time to PSA Nadir Following Primary Androgen Deprivation Therapy Are the Early Survival Predictors for Prostate Cancer Patients with Bone Metastasis

Urology ◽

10.1016/j.urology.2011.07.371 ◽

2011 ◽

Vol 78 (3) ◽

pp. S147-S148

Author(s):

T. Sasaki ◽

T. Onishi ◽

A. Hoshina

Keyword(s):

Prostate Cancer ◽

Bone Metastasis ◽

Cancer Patients ◽

Specific Antigen ◽

Psa Nadir ◽

Primary Androgen Deprivation ◽

Survival Predictors

Prostate Specific Antigen Half-Time and Prostate Specific Antigen Doubling Time as Predictors of Response to Androgen Deprivation Therapy for Metastatic Prostate Cancer

The Journal of Urology ◽

10.1016/j.juro.2009.01.104 ◽

2009 ◽

Vol 181 (6) ◽

pp. 2520-2525 ◽

Cited By ~ 28

Author(s):

Yong Hyun Park ◽

In Sik Hwang ◽

Chang Wook Jeong ◽

Hyeon Hoe Kim ◽

Sang Eun Lee ◽

...

Keyword(s):

Prostate Cancer ◽

Doubling Time ◽

Specific Antigen ◽

Androgen Deprivation ◽

Half Time ◽

Predictors Of Response

1820 CLINICAL OUTCOMES FOLLOWING PRIMARY ANDROGEN DEPRIVATION THERAPY AMONG MEN WITH LOCALIZED PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2012.02.1886 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Grace Lu-Yao ◽

Dirk Moore ◽

Weichung Shih ◽

Yong Lin ◽

Robert DiPaola ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcomes ◽

Androgen Deprivation ◽

Localized Prostate Cancer ◽

Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer

Asian Journal of Andrology ◽

10.4103/aja.aja_9_19 ◽

2019 ◽

Vol 21 (6) ◽

pp. 635

Author(s):

Akihiro Yano ◽

Makoto Kagawa ◽

Hideki Takeshita ◽

Yohei Okada ◽

Makoto Morozumi ◽

...

Keyword(s):

Prostate Cancer ◽

Dehydroepiandrosterone Sulfate ◽

Androgen Deprivation ◽

Association of Time to PSA Nadir and Logarithm of PSA Velocity After Progression in Metastatic Prostate Cancer with Prior Primary Androgen Deprivation Therapy

Asian Journal of Andrology ◽

10.4103/1008-682x.164921 ◽

2015 ◽

Vol 0 (0) ◽

pp. 0

Author(s):

SamsonYS Chan ◽

PeterKF Chiu ◽

Kwan-Lun Ho ◽

SimonSM HOU ◽

Chi-Fai NG ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation ◽

Psa Velocity ◽

Psa Nadir ◽

Prognostic Significance of Time to Prostate-Specific Antigen (PSA) Nadir and Its Relationship to Survival Beyond Time to PSA Nadir for Prostate Cancer Patients With Bone Metastases After Primary Androgen Deprivation Therapy

Annals of Surgical Oncology ◽

10.1245/s10434-014-4105-8 ◽

2014 ◽

Vol 22 (4) ◽

pp. 1385-1391 ◽

Cited By ~ 14

Author(s):

Jeremy Yuen Chun Teoh ◽

James Hok Leung Tsu ◽

Steffi Kar Kei Yuen ◽

Samson Yun Sang Chan ◽

Peter Ka Fung Chiu ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Prognostic Significance ◽

Specific Antigen ◽

Psa Nadir ◽

Correlation of baseline serum testosterone (T) and serum prostate-specific antigen (PSA) at 7 months (7 mo PSA) in patients (pts) with new hormone sensitive metastatic prostate cancer (mHSPC) treated with continuous androgen deprivation therapy (cADT).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e16019 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e16019-e16019

Author(s):

Shiven B. Patel ◽

Tyler Howard Buckley ◽

David Gill ◽

Srinivas Kiran Tantravahi ◽

Julia A. Batten ◽

...

Keyword(s):

Prostate Cancer ◽

Specific Antigen ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Baseline Serum ◽

Serum Prostate Specific Antigen ◽

Hormone Sensitive

Missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e17051 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e17051-e17051

Author(s):

Masaki Shiota ◽

Naohiro Fujimoto ◽

Kenjiro Imada ◽

Eiji Kashiwagi ◽

Ario Takeuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation ◽

Japanese Men ◽

MP07-13 BASELINE SERUM DEHYDROEPIANDROSTERONE SULFATE (DHEAS) CAN PREDICT RESPONSIVENESS TO PRIMARY ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH HORMONE NAÏVE METASTATIC PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.2216 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Akihiro Yano ◽

Hironori Sugiyama ◽

Eiken Cho ◽

Hideki Takeshita ◽

Yohei Okada ◽

...

Keyword(s):

Prostate Cancer ◽

Dehydroepiandrosterone Sulfate ◽

Androgen Deprivation ◽

Baseline Serum ◽